Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Jefferson Adams
    Jefferson Adams

    First Wave BioPharma to Present Two Abstracts on Celiac Disease Research at 2024 Digestive Disease Week (DDW) Conference

    Reviewed and edited by a celiac disease expert.

    First Wave BioPharma, a leading biopharmaceutical company specializing in gastrointestinal (GI) diseases, is set to unveil groundbreaking research on celiac disease at the upcoming 2024 Digestive Disease Week (DDW) Conference.

    Celiac.com 04/24/2024 - First Wave BioPharma, a leading biopharmaceutical company specializing in gastrointestinal (GI) diseases, is set to unveil groundbreaking research on celiac disease at the upcoming 2024 Digestive Disease Week (DDW) Conference. This announcement comes with the acceptance of two abstracts for presentation at the esteemed event, scheduled for May 18-21, 2024, in Washington, D.C.

    The first abstract, titled "A Composite Mucosal Scale for Celiac Disease Encompassing both Morphology and Inflammation," will introduce VCIEL, a novel quantitative composite scale. VCIEL combines key histologic measurements—villus height to crypt depth ratio (Vh:celiac disease) and density of intraepithelial lymphocytes (IEL)—to enhance the accuracy of assessing small intestinal mucosal health in celiac disease patients. This innovation promises to revolutionize clinical trials by providing more precise endpoint measurements.

    Celiac.com Sponsor (A12):
    The second abstract, "Dynamics of Serologic Change to Gluten in Celiac Disease Patients," delves into the complexities of diagnosing celiac disease. The study draws from a vast clinical database to investigate critical aspects, including the impact of gluten reintroduction on seropositivity and the correlation between different tTG-IgA assays. These findings have significant implications for improving diagnostic accuracy and patient management strategies.

    James Sapirstein, Chairman and CEO of First Wave BioPharma, expressed excitement about the potential impact of their research on advancing the diagnosis and management of celiac disease. Jack Syage, PhD, President and Chief Operating Officer of First Wave, emphasized the validation of their work through the invitation to present at DDW 2024—a testament to the company's commitment to enhancing understanding and treatment options for individuals with celiac disease.

    This pioneering research from First Wave BioPharma represents a significant step forward in the quest for precision diagnostics and targeted therapies for celiac disease, offering hope for improved outcomes and quality of life for affected individuals.

    Read more at: Stockhouse.com


    User Feedback

    Recommended Comments

    There are no comments to display.



    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

    >VIEW ALL ARTICLES BY JEFFERSON ADAMS

     


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Jefferson Adams
    Can Diet and Mucosal Immune Response Drive Persistent Symptoms in Gluten-Free Celiac Patients?
    Celiac.com 05/07/2019 - What causes persistent symptoms in celiac patients who are following a gluten-free diet? Many people with celiac disease suffer from persistent symptoms, even with healthy intestinal mucosa, and while following a gluten-free diet.
    A team of researchers recently set out to explore the role of dietary factors, distinct small-bowel mucosal immune cell types, and epithelial integrity in the perpetuation of gastrointestinal symptoms in gluten-free celiac disease patients.
    The research team included Pilvi Laurikka, MD; Katri Lindfors, PhD; Mikko Oittinen, MSc; Heini Huhtala, MSc; Teea Salmi, MD, PhD; Marja-Leena Lähdeaho, MD; Tuire PhIlus, MD, PhD; Markku Mäki, MD, PhD; Katri Kaukinen, MD, PhD; and Kalle Kurppa, MD, PhD.
    They are variously affiliated w...


    Vijay Kumar, Ph.D. FACB
    How Effective are the Serological Methods of Diagnosing Celiac Disease?
    Celiac.com 04/22/2023 - Celiac disease is an autoimmune disorder that may occur in genetically susceptible individuals. It is initiated by ingestion of gluten present in cereals, primarily wheat and to a much lesser extent other cereal proteins such as prolamines of barley and rye. Celiac disease is characterized by malabsorption resulting from inflammatory injury to the small intestinal mucosa. The classical symptoms of celiac disease include diarrhea, weight loss and malnutrition, however, only a small percentage of patients with celiac disease present with classical symptoms. Such patients represent the tip of the iceberg of gluten sensitivity. Many patients with celiac disease may present with short stature, iron and folate deficiency, anemia, bone loss, aphthous stomatitis, arthralgia...


    Jefferson Adams
    Potential New Treatments for Celiac Disease Touted at Digestive Disease Week
    Celiac.com 06/21/2023 - Celiac disease, which is an autoimmune disorder triggered by gluten ingestion, currently lacks effective drug therapies. To recover and remain healthy, everyone with celiac disease must adhere to a strict gluten-free diet throughout their lives. But this approach is expensive, cumbersome, and often falls short in achieving full mucosal healing and symptom control. 
    Consequently, researchers are actively seeking innovative treatments that target the underlying mechanisms of the disease. One area of promising research focuses on developing therapies that specifically target gene variants associated with celiac disease, such as the HLA-DQ2 gene.
    Various clinical trials are underway to investigate potential treatments for celiac disease. For example, the ...


    Jefferson Adams
    Groundbreaking Research Uncovers Skin Biomarkers for Food Allergy Risk
    Celiac.com 04/22/2024 - Food allergies, especially common in childhood, can pose serious threats to health, sometimes leading to severe or even fatal reactions. However, recent advancements in research conducted at National Jewish Health offer hope for early intervention to prevent the development of such allergies.
    At National Jewish Health, researchers have pioneered a groundbreaking program focused on preventing food allergies. Their latest breakthrough involves the discovery of early indicators for this condition, which marks a significant stride towards proactive intervention.
    The research team identified biomarkers associated with both atopic dermatitis and food allergy, particularly abnormal lipids, microbes, and proteins present in the skin.
    In a recent study...


  • Recent Activity

    1. - cristiana replied to Kathleen JJ's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      1

      Options - 7 year old boy - Helicobacter pylori and serology

    2. - Kathleen JJ posted a topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      1

      Options - 7 year old boy - Helicobacter pylori and serology

    3. - Wheatwacked replied to CeliacChica's topic in Related Issues & Disorders
      29

      Muscle Twitching

    4. - trents replied to jjiillee's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      5

      Daughter waiting for appointment

    5. - jjiillee replied to jjiillee's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      5

      Daughter waiting for appointment


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,052
    • Most Online (within 30 mins)
      7,748

    Kathleen JJ
    Newest Member
    Kathleen JJ
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.1k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • Captain173
      10
    • jjiillee
      5
    • Kristina12
      7
    • StaciField
    • ShRa
      9
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...